Wire · regulatory
Viatris Receives U.S. FDA Approval for Gwyn Lo™, a Once-Weekly Contraceptive Patch
◆ Sectors
Femtech
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 29 July 2026 · Fusion42 review
Viatris has received U.S. FDA approval for Gwyn Lo™, a new once-weekly, low-dose estrogen contraceptive patch. The patch is indicated for women with a BMI under 30 kg/m² and is expected to be commercially available later in 2026.
This Wire brief sits within Fusion42's coverage of Femtech, and 2 sources have reported it.
◆ ◆ The Wire takeaway
A new convenience benchmark has been set in the US contraceptive market with a once-weekly patch. If you're building a daily-use product, you now have a direct competitor focused on user experience.
◆ Coverage
2 sources · 29 Jul 2026
◆ Related on Wire
◆ Topics
Femtechfemtechcontraceptionfda-approvalwomens-healthdrug-delivery